MedTrace Logo

T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

NCT04220450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2020-01-07

No results posted yet for this study

Summary

On clinically indicated Cardiovascular Magnetic Resonance studies, native T1-times and extracellular volume of the liver will be assessed and findings correlated with established risk calculators for non-alcoholic fatty liver disease.

Conditions

Interventions

DIAGNOSTIC_TEST

T1 mapping on Cardiovascular Magnetic Resonance Studies

On clinically indicated Cardiovascular Magnetic Resonance Imaging Studies, native T1-times and extracellular volume will be determined

Sponsors & Collaborators

  • Dr. Andreas Kammerlander

    lead OTHER

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-01
Completion
2021-06-15

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220450 on ClinicalTrials.gov